Mortalidad intrahospitalaria en choque cardiogénico: Pacientes con infarto agudo de miocardio tratados con angioplastia coronaria
@inproceedings{GalvnGarca2011MortalidadIE, title={Mortalidad intrahospitalaria en choque cardiog{\'e}nico: Pacientes con infarto agudo de miocardio tratados con angioplastia coronaria}, author={Jos{\'e} Eduardo Galv{\'a}n-Garc{\'i}a and Juan Manuel Palacios-Rodr{\'i}guez and Samuel Cant{\'u}-Ram{\'i}rez and Juan Francisco Vargas-Ram{\'i}rez and Brenda Judith Medell{\'i}n-Moreno and Eliud Baena-Santill{\'a}n and Ivan S{\'a}nchez-Rodr{\'i}guez and Guillermo Bernardo Ficker-Lacayo and Juan Alberto M{\'e}ndez-Ch{\'a}vez and Gilmer Cetina-Dom{\'i}nguez and Edgar Armando Mor{\'a}n-Benavente and Efr{\'e}n Melano-Carranza and Alejandro Leos and G Tolosa-Dzul and Ra{\'u}l Becerra Ontiveros and G. Calarza Lopez}, year={2011} }
Jose Eduardo Galvan-Garcia,* Juan Manuel Palacios-Rodriguez,* Samuel Cantu-Ramirez,* Juan Francisco Vargas-Ramirez,* Brenda Judith Medellin-Moreno,* Eliud Baena-Santillan,* Ivan Alejandro Sanchez-Rodriguez,* Guillermo Bernardo Ficker-Lacayo,* Juan Alberto Mendez-Chavez,* Gilmer Cetina-Dominguez,* Edgar Armando Moran-Benavente,* E Melano-Carranza,* Alejandro Leos,* Gonzalo Tolosa-Dzul,* Raul Ontiveros,* Gustavo Lopez*
References
SHOWING 1-10 OF 33 REFERENCES
RENASICA II. Registro Mexicano de Síndromes Coronarios Agudos
- Medicine
- 2005
El mas grande registro de sindromes coronarios agudos en Latinoamerica provee informacion importante sobre el espectro clinico, evolucion hospitalaria, calidad de atencion e identifica areas of oportunidad para mejorar the atencions medica.
Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
- MedicineJournal of the American College of Cardiology
- 2000
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
- MedicineJournal of the American College of Cardiology
- 1995
Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry.
- Medicine, BiologyEuropean heart journal
- 2006
CS on admission patients have a worse outcome but benefit equally from emergency revascularization as delayed CS patients, emphasizing the need for rapid and direct access of CS on admission Patients to facilities providing this care.
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
- MedicineJournal of the American College of Cardiology
- 2000
Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.
- MedicineJournal of the American College of Cardiology
- 2001
Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.
- MedicineThe American journal of cardiology
- 2002
Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival.
- MedicineJournal of the American College of Cardiology
- 1998
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
- MedicineEuropean heart journal
- 2004
Impact of invasive strategy for the management of patients with cardiogenic shock after acute myocardial infarction
- MedicineCoronary artery disease
- 2004
It is suggested that early revascularization improves long-term survival of patients with cardiogenic shock complicating acute myocardial infarction, even after adjustment for baseline differences between patients who underwent earlyRevascularization and those who did not.